4DMedical Annual Report 2021 - Lung Imaging IPO

4DMedical's 2021 Annual Report documents a pivotal year marked by the company's August 2020 IPO on the ASX and significant expansion of lung imaging technology. The report highlights commercialization of the XVD Scanner™, a dedicated lung scanner integrated with XV Technology™, supported by $28.9M in government funding from the MRFF Frontier initiative and a $50M capital raise.